Recorded Chinese product: 醋酸甲地孕酮片醋酸甲地孕酮片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 上海信谊天平药业有限公司Chinese legal name: 上海信谊天平药业有限公司
主要成分Active Ingredients
- 甲地孕酮Jiadi Yuntong
药物知识说明
甲地孕酮是一种在国家药监局注册认定的药品。该药品含有甲地孕酮-02dc6577等成分。
该药品关联的活性成分包括：甲地孕酮Jiadi Yuntong。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：上海信谊天平药业有限公司Chinese legal name: 上海信谊天平药业有限公司。
您可以探索含有相同成分的其他药品：甲地孕酮-02dc6577成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 醋酸甲地孕酮片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 甲地孕酮Jiadi Yuntong.
Manufacturers recorded for this product: 上海信谊天平药业有限公司Chinese legal name: 上海信谊天平药业有限公司.
Explore other medicines containing the same ingredient: 甲地孕酮 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 醋酸甲地孕酮片Recorded Chinese product: 醋酸甲地孕酮片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 160mg160 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 上海信谊天平药业有限公司Chinese legal name: 上海信谊天平药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20053712
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20053712
Manufacturer
Chinese legal name: 上海信谊天平药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20053712
生产企业
上海信谊天平药业有限公司(国产)
适应症
本品适用于晚期乳腺癌和子宫内膜癌的姑息治疗（即复发性、不能手术的或已经转移的患者）。不能替代目前接受的手术，放射或化学治疗。
用法用量
乳腺癌:一日160mg，一日剂量，一次或分次服用。子宫内膜癌:根据疾病的情况，一日40―320mg，一日剂量，一次或分次服用。或遵医嘱。
不良反应
1.主要为恶心头晕倦怠
2.突破性出血
3.孕期服用有比较明确的增加女性后代男性化的作用
禁忌
1.对本品种的任何成份过敏者禁用.
2.严重肝功能不全.
3.血栓性静脉炎及血栓患者.
4.妊娠诊断试验.
注意事项
1.治疗前排除妊娠。
2.治疗期间必须有安全的避孕措施。
3.不应推荐在妊娠最初四个月内使用孕酮类药物。
4.如果在妊娠最初四个月内使用了本品，应将本品对胎儿的潜在危险告知患者。
5.正在使用本品的育龄妇女应劝其不要怀孕。
6.常规的密切监测适用于所有采用本品治疗的复发性或转移性肿瘤患者，具有血栓性静脉炎病史的患者应慎用。
贮藏
室温(25℃)储存，避免超过40℃。
规格
160mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.